Astera Labs (NASDAQ:ALAB) Coverage Initiated by Analysts at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft assumed coverage on shares of Astera Labs (NASDAQ:ALABFree Report) in a report released on Monday, Marketbeat reports. The brokerage issued a buy rating and a $85.00 price objective on the stock.

A number of other research analysts have also issued reports on the stock. Roth Mkm initiated coverage on shares of Astera Labs in a research note on Monday. They issued a buy rating and a $85.00 target price on the stock. Needham & Company LLC began coverage on shares of Astera Labs in a research note on Monday. They set a buy rating and a $85.00 target price for the company. Barclays assumed coverage on shares of Astera Labs in a research report on Monday. They issued an overweight rating and a $85.00 price target on the stock. Stifel Nicolaus started coverage on shares of Astera Labs in a research note on Monday. They issued a buy rating and a $81.00 target price for the company. Finally, Northland Securities began coverage on Astera Labs in a research note on Monday, March 25th. They set an outperform rating and a $85.00 price target on the stock. Eleven research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has a consensus rating of Buy and an average price target of $86.09.

View Our Latest Stock Report on Astera Labs

Astera Labs Stock Performance

Shares of ALAB stock opened at $70.92 on Monday. Astera Labs has a 12 month low of $50.61 and a 12 month high of $95.21.

Insider Activity

In related news, Director Jack R. Lazar bought 10,000 shares of the business’s stock in a transaction that occurred on Friday, March 22nd. The stock was acquired at an average price of $36.00 per share, for a total transaction of $360,000.00. Following the transaction, the director now directly owns 165,000 shares of the company’s stock, valued at $5,940,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Institutional Investors Weigh In On Astera Labs

An institutional investor recently bought a new position in Astera Labs stock. Allspring Global Investments Holdings LLC purchased a new stake in Astera Labs, Inc. (NASDAQ:ALABFree Report) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 251,596 shares of the company’s stock, valued at approximately $18,666,000. Allspring Global Investments Holdings LLC owned approximately 0.16% of Astera Labs as of its most recent SEC filing.

About Astera Labs

(Get Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

See Also

Analyst Recommendations for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.